Catalyst Reaction · NASDAQ: CUE · Biotechnology
Cue Biopharma (CUE): quarterly results, a 79.9% drop and what followed
Cue Biopharma (CUE) announced third quarter 2026 financial results and recent business highlights at 4:48 PM ET on Monday, November 16, and the stock went from Monday’s $14.10 close to as low as $2.83. It finished the session −79.9% at $2.83 on 28.8 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.
By IndicatorStack · · All times ET
The catalyst
What the company released or filed, to the minute it crossed. It’s in the timeline as a shaded row, linked to the source.
How it traded
The price around it, session by session: the gap, the range, the close, with the chart LiveChart draws from those bars.
How the stack read it
LiveChart’s read at each turn: the 5-minute trend (the stack bias), the higher timeframes (Compass), the flow (Undertow) and traps (Tripwire).
How the stack read it, checkpoint by checkpoint
The stack bias is LiveChart’s read of the 5-minute trend at that moment: a green dot is bullish, red bearish, grey no clear direction. Under it, what Compass read on the higher timeframes the trend is measured against.
- BeforeNeutralMon close · $14.1015m and 1h down
- Into the openBearishTue 9:30 AM · $13.0115m and 1h down
- 30 minutes inBearishTue 10:00 AM · $9.0815m and 1h down
- At the closeBearishTue 4:00 PM · $2.9115m and 1h down
- Wednesday’s closeBullishWed 4:00 PM · $4.7315m and 1h still down
The timeline
Everything that happened, in order, on one ET clock: the company’s releases and SEC filings next to the price and the stack’s own turns.
- ReleaseSECShaded rows are the catalyst: the company’s own releases and filings
- PriceThe session’s open, high, low and close
- StackLiveChart’s 5-minute bias changed
- TriggerA hypothetical entry at the default settings
- TripwireA break of a level that failed to hold
Monday, November 16
- SECOwnership stake over 5% (Schedule 13G) filedAccepted by the SEC at 6:02:14 AM ET
- SECAmended ownership stake (Schedule 13G/A) filedAccepted by the SEC at 9:43:56 AM ET
- SECOwnership stake over 5% (Schedule 13G) filedAccepted by the SEC at 2:00:26 PM ET
- ReleaseThird quarter 2026 financial results and recent business highlightsPress release, GlobeNewsWire
- SECCurrent report (Form 8-K) filedAccepted by the SEC at 4:52:54 PM ET
Tuesday, November 17
- PricePremarket high $13.80−2.1% from the prior close
- PriceOpened at $13.02−7.7% from Monday’s $14.10 close
- TripwireTripwire flagged a trap at the lowsa push through support that failed to hold, at $9.08
- PriceSession low $2.83
- PriceClosed at $2.83, −79.9% on the day4.2M shares, 28.8× its 20-day average
Wednesday, November 18
- Stack5-minute stack bias turned bullishat $3.34
- PriceOpened at $3.41+20.5% from Tuesday’s $2.83 close
- PriceSession low $3.27
- TriggerTrigger marked a short at $3.36Hypothetical, default settings: closed at $3.88 at 9:50 AM for −15.5% (stop)
- PriceSession high $4.77
- PriceClosed at $4.76, +68.2% on the day13.2M shares, 37.8× its 20-day average
Monday, November 16
Before the catalyst
Cue Biopharma closed Monday at $14.10. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h down” (15m ↘ 1h ↓ 2h ↓ 4h ↘ D ↓). Undertow: buyers lead, no large size yet. Tripwire: Shorts: Clean, nothing major in the way. Its Next row read “Range 14.01 to 14.58, no edge in the middle”.
Over the year before, it had traded between $4.97 and $45.50. The daily chart below shows where it was trading, and the bar the catalyst printed.
Neutral5m stack bias · $14.10
- Compass
- 15m and 1h down
- Undertow
- Buyers lead
- Tripwire
- Shorts: Clean
- Next
- Range 14.01 to 14.58, no edge in the middle
Tuesday, November 17
The quarterly results and a 79.9% drop
The release crossed at 4:48 PM ET on Monday. It opened at $13.02, −7.7%, and the regular session ranged from $2.83 to $13.52 before closing at $2.83. It did this on a day SPY fell 1.0% and XBI, the biotechnology ETF, fell 0.4%.
Into the open the stack read it as bearish (strong) with 2 of 2 higher timeframes down, and Undertow read “selling drying up”. Thirty minutes in, the picture had changed: price was below VWAP at $12.19 and the Next row read “Stretched below the averages, bounce area near 10.93”. By the close the 5-minute bias was bearish from 6:35 PM, while Compass still read “15m and 1h down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.
Bearishstrong · 5m stack bias · $13.01
- Compass
- 15m and 1h down
- Undertow
- Selling drying up
- Tripwire
- Shorts: Clean
- Next
- Stretched below the averages, bounce area near 13.42
Bearishstrong · 5m stack bias · $9.08
- Compass
- 15m and 1h down
- Undertow
- Sellers in control
- Tripwire
- Shorts: Clean
- Next
- Stretched below the averages, bounce area near 10.93
Bearishfirm · 5m stack bias · $2.91
- Compass
- 15m and 1h down
- Undertow
- Selling drying up
- Tripwire
- Shorts: Avoid
- Next
- Stretched below the averages, bounce area near 3.29
Wednesday, November 18
The session after
It opened at $3.41 (+20.5%) and traded from $3.27 to $4.77, closing at $4.76, +68.2% on 13.2M shares, still 37.8 times its 20-day average. The 5-minute stack bias was bullish (firm), since 7:15 AM: over VWAP 4.25 and a rising SMA, momentum up and trend strength with the buyers. Compass read “15m and 1h still down” (15m ↘ 1h ↘ 2h ↘ 4h ↘ D ↘). Undertow: buying drying up, price higher, flow lower. Tripwire: Longs: Clean, nothing major in the way.
After hours it last traded at $4.79, with Undertow reading “hidden buying”.
Bullishfirm · 5m stack bias · $4.73
- Compass
- 15m and 1h still down
- Undertow
- Buying drying up
- Tripwire
- Longs: Clean
- Next
- Buying drying up near 4.67, giveback risk rising
Neutral5m stack bias · $4.79
- Compass
- 15m and 1h down
- Undertow
- Hidden buying
- Tripwire
- Longs: Avoid
- Next
- Range 4.70 to 5.08, no edge in the middle
Shares, float and insiders
The supply picture
What the company has outstanding, and what its insiders and its share history show, from its SEC filings.
- Shares outstanding
- 7.3Mas reported to the SEC
- Float
- 5.8M80% of shares outstanding
- Reverse splits on record
- 11-for-30 reverse split, April 24, 2026
- Last insider purchase
- June 1, 202691K shares at $0.0010 by Lin Shao-Lee (director, officer: Chief Executive Officer)
- Last insider sale
- October 12, 20262K shares at $28.05
Releases and filings
Sources
The company’s own releases and its filings with the SEC, newest first, each with the time it crossed.
- SECCurrent report (Form 8-K)Mon Nov 16, 4:52 PM ET · SEC EDGAR
- ReleaseThird quarter 2026 financial results and recent business highlightsMon Nov 16, 4:48 PM ET · GlobeNewsWire
- SECOwnership stake over 5% (Schedule 13G)Mon Nov 16, 2:00 PM ET · SEC EDGAR
- SECAmended ownership stake (Schedule 13G/A)Mon Nov 16, 9:43 AM ET · SEC EDGAR
- SECOwnership stake over 5% (Schedule 13G)Mon Nov 16, 6:02 AM ET · SEC EDGAR
- SECAmended ownership stake (Schedule 13G/A)Tue Nov 10, 4:58 PM ET · SEC EDGAR
In short
Questions
Why did CUE stock go down on November 17?
Cue Biopharma (CUE) announced third quarter 2026 financial results and recent business highlights at 4:48 PM ET on Monday, November 16, and the stock went from Monday’s $14.10 close to as low as $2.83. It finished the session −79.9% at $2.83 on 28.8 times its 20-day average volume. The reaction describes the sequence and infers no cause.
What did Cue Biopharma announce on November 16, 2026?
Cue Biopharma (CUE) announced third quarter 2026 financial results and recent business highlights at 4:48 PM ET on Monday, November 16.
How did CUE stock trade on November 17?
CUE opened at $13.02, −7.7% from the prior close of $14.10, traded between $2.83 and $13.52 in the regular session and closed at $2.83, −79.9%, on 4.2M shares.
How did LiveChart’s stack read CUE at the close on November 17?
At the 4:00 PM ET close the 5-minute stack bias on CUE was bearish (firm), Compass read “15m and 1h down” and Undertow read “selling drying up”. Each turn of the read is on this page’s timeline.
What does LiveChart’s stack read on CUE now?
The read on this page is fixed at each moment it describes. LiveChart reads CUE on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.
Every catalyst on CUE
CUE’s catalyst history
This is CUE’s first Catalyst Reaction. Each time it moves on a release or a filing again, the reads line up here side by side, so how it reacts to its own news builds into a history.
| Session | The catalyst | The day | Next session | Stack bias at the close |
|---|---|---|---|---|
| Nov 17, 2026This reaction | Third quarter 2026 financial results and recent business highlightsEarnings · 4:48 PM ET | −79.9% | +68.2% | Bearish |
Also on Tuesday, November 17
More Catalyst Reactions from that session
- Nov 1710:00 AM ETMPU+65.6%Mega Matrix (MPU): Former Polygon Labs and Mega Matrix Exec Colin, a 65.6% session and what followedCompany news746.1× avg volume
- Nov 178:55 AM ETAYTU+46.2%Aytu BioPharma (AYTU): shareholder Alert: Ademi LLP, a 46.2% session and what followedCompany news44.7× avg volume
- Nov 177:32 AM ETFRTT+77.7%Fort Technology (FRTT): record Year-to-Date revenues of $12 million, a 77.7% session and what followedCompany news38.2× avg volume
- Nov 177:00 AM ETSLS+156.4%SELLAS (SLS): Phase 3 data, a 156% session and a $13.00 offeringTrial data15.7× avg volume
- Nov 177:00 AM ETSMTK+66.0%SmartKem (SMTK): merger partner Ferrox advances Global, a 66.0% session and what followedCompany news103.3× avg volume
- Nov 176:00 AM ETGLSI+35.9%Greenwich LifeSciences (GLSI): Acceptance of abstracts at SABCS 2026, a 35.9% session and what followedCompany news8.6× avg volume
Every Reaction From Nov 17More Earnings ReactionsCUE Catalyst HistoryCUE on LiveChartTechnical Setups RadarAll Catalyst ReactionsIntraday Movers
Further reading: Gaps: continuation and exhaustionLow-float riskWhat VWAP tells youTrading around halts
General market information from the company’s releases, its SEC filings, the session’s prices and LiveChart’s reads. Prices are indicative. It describes what happened and when, infers no cause, takes no view on what comes next and is not a recommendation to buy or sell any security. Trigger trades are hypothetical. Read the Risk Disclosure.